- Home
- ZUMZ vs ITOS Comparison
ZUMZ vs ITOS Comparison
Compare ZUMZ & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- ITOS
- Stock Information
- Founded
- ZUMZ 1978
- ITOS 2011
- Country
- ZUMZ United States
- ITOS United States
- Employees
- ZUMZ N/A
- ITOS N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZUMZ Consumer Discretionary
- ITOS Health Care
- Exchange
- ZUMZ Nasdaq
- ITOS Nasdaq
- Market Cap
- ZUMZ 247.5M
- ITOS 270.7M
- IPO Year
- ZUMZ 2005
- ITOS 2020
- Fundamental
- Price
- ZUMZ $12.49
- ITOS $10.02
- Analyst Decision
- ZUMZ Hold
- ITOS Hold
- Analyst Count
- ZUMZ 2
- ITOS 6
- Target Price
- ZUMZ $22.00
- ITOS $10.60
- AVG Volume (30 Days)
- ZUMZ 220.1K
- ITOS 2.6M
- Earning Date
- ZUMZ 06-05-2025
- ITOS 04-28-2025
- Dividend Yield
- ZUMZ N/A
- ITOS N/A
- EPS Growth
- ZUMZ N/A
- ITOS N/A
- EPS
- ZUMZ N/A
- ITOS N/A
- Revenue
- ZUMZ $889,202,000.00
- ITOS $35,000,000.00
- Revenue This Year
- ZUMZ $3.19
- ITOS N/A
- Revenue Next Year
- ZUMZ $1.71
- ITOS $31.74
- P/E Ratio
- ZUMZ N/A
- ITOS N/A
- Revenue Growth
- ZUMZ 1.57
- ITOS 177.89
- 52 Week Low
- ZUMZ $11.31
- ITOS $4.80
- 52 Week High
- ZUMZ $31.37
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- ZUMZ 47.58
- ITOS 73.75
- Support Level
- ZUMZ $11.66
- ITOS $8.30
- Resistance Level
- ZUMZ $13.31
- ITOS $11.35
- Average True Range (ATR)
- ZUMZ 0.50
- ITOS 0.53
- MACD
- ZUMZ 0.03
- ITOS 0.22
- Stochastic Oscillator
- ZUMZ 40.89
- ITOS 71.15
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.